Skip to main content

Published locations for VIDEO: Ibrutinib should be therapy ‘backbone’ in relapsed CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. VIDEO: Ibrutinib should be therapy ‘backbone’ in relapsed CLL

User login

  • Reset your password
  • /content/video-ibrutinib-should-be-therapy-backbone-relapsed-cll
  • /hematologynews/article/100579/cll/video-ibrutinib-should-be-therapy-backbone-relapsed-cll
  • /oncologypractice/article/100579/cll/video-ibrutinib-should-be-therapy-backbone-relapsed-cll
  • /hematology-oncology/article/100579/cll/video-ibrutinib-should-be-therapy-backbone-relapsed-cll
  • /b-cell-lymphoma-icymi/article/100579/cll/video-ibrutinib-should-be-therapy-backbone-relapsed-cll